The existing standard of care measures for kidney function, proteinuria, and serum creatinine (SCr) are poor predictors of early-stage kidney disease. Rating, and scientific thresholds correlate with set up chronic kidney disease (CKD) and could provide predictive details on early…
Octreotide and everolimus have demonstrated efficacy in neuroendocrine tumors. patient; 17
Octreotide and everolimus have demonstrated efficacy in neuroendocrine tumors. patient; 17 (81%) patients experienced at least some tumor regression as their best response to therapy. In conclusion, pasireotide LAR 60 mg IM monthly in combination with everolimus 10 mg daily…